GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $37,000 | -5.1% | 106,061 | +25.9% | 0.00% | – |
| Q2 2016 | $39,000 | -66.9% | 84,271 | -3.0% | 0.00% | – |
| Q1 2016 | $118,000 | +7.3% | 86,891 | +15.9% | 0.00% | – |
| Q4 2015 | $110,000 | -33.3% | 74,969 | -28.2% | 0.00% | – |
| Q3 2015 | $165,000 | -9.8% | 104,385 | -3.0% | 0.00% | – |
| Q2 2015 | $183,000 | +38.6% | 107,641 | +13.0% | 0.00% | – |
| Q1 2015 | $132,000 | +25.7% | 95,278 | +36.7% | 0.00% | – |
| Q4 2014 | $105,000 | -30.0% | 69,686 | -4.5% | 0.00% | – |
| Q3 2014 | $150,000 | -33.9% | 72,977 | -1.8% | 0.00% | – |
| Q2 2014 | $227,000 | +7.6% | 74,288 | -11.9% | 0.00% | – |
| Q1 2014 | $211,000 | -45.9% | 84,309 | +7.3% | 0.00% | – |
| Q4 2013 | $390,000 | +163.5% | 78,580 | +21.1% | 0.00% | – |
| Q3 2013 | $148,000 | +24.4% | 64,880 | +21.4% | 0.00% | – |
| Q2 2013 | $119,000 | – | 53,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |